Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Advances and Issues in NSCLC
EP. 1: Squamous Cell Carcinoma Treatment Options
February 13th 2013
EP. 2: Introduction: Advances and Issues in NSCLC
February 13th 2013
EP. 3: Best Practices in NSCLC Molecular Testing, Part I
February 13th 2013
EP. 4: Concurrent Versus Sequential Testing in NSCLC
February 13th 2013
EP. 5: Best Practices in NSCLC Molecular Testing, Part II
February 13th 2013
EP. 6: Molecular Testing and Actionable Targets in NSCLC
February 13th 2013
EP. 7: Rebiopsying and Molecular Testing in NSCLC
February 13th 2013
EP. 8: Selecting a Laboratory for Molecular Testing in NSCLC
February 13th 2013
EP. 9: Selecting Treatment for First- Line Non-Squamous NSCLC
February 13th 2013
EP. 10: Molecular Heterogeneity in Non-Small Cell Lung Cancer
February 13th 2013
EP. 11: Promising Emerging Classes of Therapies in NSCLC
February 13th 2013
EP. 12: Personalizing the Treatment of Lung Cancer
February 13th 2013
EP. 13: Access to Molecular Testing Therapy in NSCLC
February 13th 2013
EP. 14: Impact of EGFR Mutations on Treatment Decisions in NSCLC
February 13th 2013
EP. 15: The Cost-Effectiveness of Targeted Therapies in NSCLC
February 13th 2013